New Millennium Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$162K Buy
2,037
+1,220
+149% +$96.2K 0.07% 76
2025
Q3
$61.6K Buy
+817
New +$56K 0.03% 104
2024
Q3
Sell
-7
Closed -$413 414
2024
Q2
$413 Buy
+7
New +$438 ﹤0.01% 379
2024
Q1
Sell
-10
Closed -$810 145
2023
Q4
$810 Buy
10
+5
+100% +$356 ﹤0.01% 365
2023
Q3
$363 Hold
5
﹤0.01% 371
2023
Q2
$357 Sell
5
-579
-99% -$41.2K ﹤0.01% 379
2023
Q1
$43.4K Sell
584
-85
-13% -$7.13K 0.04% 110
2022
Q4
$62.4K Sell
669
-233
-26% -$22.5K 0.07% 83
2022
Q3
$85K Sell
902
-10
-1% -$990 0.09% 71
2022
Q2
$84K Buy
+912
New +$89K 0.09% 73

Other funds holding CVS

New Millennium Group's CVS Position: Q4 2025 in Review

New Millennium Group increased its CVS Health (CVS) stake by 149% in Q4 2025, buying an estimated $96.2K and bringing the position to 2,037 shares worth $162K. The position accounts for 0.07% of the portfolio, ranked #76.

New Millennium Group first reported a position in CVS in Q2 2022 and has held it in 10 quarters since. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • New Millennium Group held 2,037 shares of CVS Health worth $162K as of Q4 2025.
  • New Millennium Group bought 1,220 CVS Health shares in Q4 2025, an estimated $96.2K.
  • CVS Health made up 0.07% of New Millennium Group's portfolio in Q4 2025, its #76 holding.
  • New Millennium Group first reported a position in CVS Health in Q2 2022 and has held it in 10 quarters since.
  • 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.